PreprintAll rights reservedmedRxiv
Proteomic markers linking anxiety phenotypes to Alzheimers disease risk: a multi-analyte proteomic analysis
- 1University of Pittsburgh
Related
- Alzheimers disease blood biomarkers reveal proteomic modules of disease progression
- Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension
- Psychological processes linking insomnia with depression and anxiety in emerging adulthood
- Association between plasma brain-derived p-tau variants and anxiety phenotypes in older adults
- Integrated single-cell and proteomic profiling of pancreatic neoplasia identifies tissue markers that outperform established diagnostic markers in distinguishing cancer from precursor lesions.
BibTeX
@misc{costa2026proteomic,
title = {{Proteomic markers linking anxiety phenotypes to Alzheimers disease risk: a multi-analyte proteomic analysis}},
author = {A. P. Costa and H. T. Karim and M. F. Farinas and M. M. Geissinger and X. Zeng and D. L. Tudorascu and M. A. Butters and T. K. Karikari and C. Andreescu},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.16.26363134},
url = {https://www.medrxiv.org/content/10.64898/2026.09.16.26363134v1},
}
RIS
TY - UNPB
TI - Proteomic markers linking anxiety phenotypes to Alzheimers disease risk: a multi-analyte proteomic analysis
AU - A. P. Costa
AU - H. T. Karim
AU - M. F. Farinas
AU - M. M. Geissinger
AU - X. Zeng
AU - D. L. Tudorascu
AU - M. A. Butters
AU - T. K. Karikari
AU - C. Andreescu
PY - 2026
DA - 2026/09/16
PB - medRxiv
DO - 10.64898/2026.09.16.26363134
UR - https://www.medrxiv.org/content/10.64898/2026.09.16.26363134v1
ER -